1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine
C18H35N3 — CID 106649218
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine
1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine (PubChem CID 106649218) has the molecular formula C18H35N3 and a molecular weight of 293.50 g/mol. Its IUPAC name is 1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine.
Molecular Properties
| Compound Name | 1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine |
|---|---|
| PubChem CID | 106649218 |
| Molecular Formula | C18H35N3 |
| Molecular Weight | 293.50 g/mol |
| Exact Mass | 293.28 |
| IUPAC Name | 1-[cycloocten-1-yl(hydrazinyl)methyl]-N,N,4-trimethylcyclohexan-1-amine |
| SMILES | CC1CCC(C(NN)C2=CCCCCCC2)(N(C)C)CC1 |
| InChI | InChI=1S/C18H35N3/c1-15-11-13-18(14-12-15,21(2)3)17(20-19)16-9-7-5-4-6-8-10-16/h9,15,17,20H,4-8,10-14,19H2,1-3H3 |
| InChIKey | WJEROLKTMKHTBB-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 41.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 293.50 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 106649218 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.